“Incretin-Based Antidiabetic Agents: A New Option for Type-2 Diabetes Mellitus”, Faridpur Med Coll J, vol. 6, no. 1, pp. 51–54, Apr. 2011, doi: 10.3329/fmcj.v6i1.7412.